Brainient — LDV Capital Blog on Visual Technologies and AI — LDV Capital
LDV Blog
We’re thrilled to announce that our portfolio company Ezra is joining Function Health – the first personalized health platform offering access to over 160 advanced lab tests and one of the fastest-growing startups in the healthcare space. Ezra perfectly aligns with Function’s mission to empower 8 billion people to live 100 healthy years.
This month, in our Women Leading Visual Tech series we are honored to showcase Esther Dyson – an investor, journalist, author, businesswoman, commentator, and philanthropist. Currently, she is a full-time executive founder of Wellville, a ten-year project (ending in 2024) to show the long-term value, in both equity and resilience, of investing in health for all.
LDV Capital’s Abigail Hunter-Syed spoke with Esther about investing in visual technology companies, genetics, AI-powered MRI-based cancer screenings, and much more!
In this article, Emi Gal talks about how Ezra is changing the game for cancer detection through visual technology. Read on to learn about his scientific research-driven approach, the long-term possibilities for Ezra.